Delivery Order SPE2DB22D2103-SPE2DB25FR9SZ
Award Date 8/29/25
Potential Completion Date 9/22/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,119.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets (5 units) on August 22, 2025, with completion targeted for September 15, 2025. This non-set-aside award represents a child order under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $5,119.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for INQOVI 35 mg-100 mg tablets (5-count units), with performance expected in Conshohocken, Pennsylvania by September 10, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product, with a total ceiling value of $5,119.36. The contract is a firm fixed-price arrangement with a performance period ending on June 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $73,826.46 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contractor, headquartered in Conshohocken, Pennsylvania, will...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,260.94 to AmerisourceBergen Drug Corp on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price contract, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), represents a child award in a non-competitive, competitively awarded vehicle. The contract does not utilize a set-aside designation....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,651.68 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $49,217.64 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside contract, issued as a competitive delivery order, represents a continuation of the federal government's reliance on AmerisourceBergen as a critical pharmaceutical distributor for military healthcare systems. The work will be performed...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, valued at $3,634.86, represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle through December 2026. AmerisourceBergen, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $122,742.87 to AmerisourceBergen Drug Corp on August 23, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order...